Research

News Research

Evaluate report signals orphan drug market is niche no more

London, UK – 28 April 2022 – Evaluate, the leading provider of market intelligence and predictive analytics for the pharmaceutical industry, has today released the findings of its 2022 Orphan Drug Report. Evaluate’s data shows that the orphan drug market is growing more than twice as fast as the non-orphan pharmaceuticals market, with 2021-2026 CAGR […]

Read More